nach oben

Erschienen in:

12.01.2019 | Dental Prophylaxis

Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study

verfasst von: Christian Grov, Anthony W. P. Flynn, Alexa B. D’Angelo, Javier Lopez-Rios, David W. Pantalone, Ian W. Holloway, Jeffrey T. Parsons

Erschienen in: Prevention Science | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015–2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.

Atreja, A., Bellam, N., & Levy, S. R. (2005). Strategies to enhance patient adherence: Making it simple. Medscape General Medicine, 7, 4.PubMedPubMedCentral

Boeni, F., Spinatsch, E., Suter, K., Hersberger, K. E., & Arnet, I. (2014). Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Systematic Reviews, 3, 29.CrossRef

Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., et al. (2011). Medication adherence: a call for action. American Heart Journal, 162, 412–424.CrossRef

Bush, S., Magnuson, D., Rawlings, K., Hawkins, T., McCallister, S., & Mera Giler, R. (2015). Racial Characteristics of FTC/TDF for pre-exposure prophylaxis (prep) users in the US Paper presented at the ASM Microbe 2016, Boston.

Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “Truvada Whores”. American Journal of Public Health, 105, 1960–1964

Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Barnighausen, T. (2014). Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS, 28, S187–S204.CrossRef

Delaney, K. P., Sanchez, T., Bowles, K., Oraka, E., DiNenno, E., & Sullivan, P. (2016). Awareness and use of PrEP appear to be increasing among internet samples of US MSM. Paper presented at the Conference on Retroviruses and Opportunistic Infections, Boston.

Dolder, C. R., Lacro, J. P., Leckband, S., & Jeste, D. V. (2003). Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology, 23, 389–399.CrossRef

Flash, C., Landovitz, R., Mera Giler, R., Ng, L., Magnuson, D., Bush Wooley, S., & Rawlings, K. (2014). Two years of Truvada for pre-exposure prophylaxis utilization in the US. Journal of the International AIDS Society, 17, 19730. https://doi.org/10.7448/IAS.17.4.19730.CrossRefPubMedPubMedCentral

Gilmore, H. J., Liu, A., Koester, K. A., Amico, K. R., McMahan, V., Goicochea, P., et al. (2013). Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx Pre-Exposure Prophylaxis Trial in San Francisco. AIDS Patient Care and STDs, 27, 560–566.CrossRef

Glidden, D. V., Anderson, P. L., & Grant, R. M. (2016). Pharmacology supports “on-demand” PrEP. The lancet. HIV, 3, e405–e406.CrossRef

Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs, 27, 248–254.CrossRef

Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., McPherson-Baker, S., Ironson, G., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413–418.CrossRef

Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., et al. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. The Lancet Infectious Diseases, 14, 820–829.CrossRef

Haberer, J. E. (2016). Current concepts for PrEP adherence: in the PrEP revolution; from clinical trials to routine practice. Current Opinion in HIV and AIDS, 11, 10–17.CrossRef

Kibengo, F. M., Ruzagira, E., Katende, D., Bwanika, A. N., Bahemuka, U., Haberer, J. E., et al. (2013). Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One, 8, e74314.

Krakower, D. S., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS and Behavior, 18, 1712–1721.CrossRef

Krakower, D. S., Jain, S., & Mayer, K. H. (2015). Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Current HIV/AIDS Reports, 12, 127–138.CrossRef

Lally, P., Van Jaarsveld, C. H. M., Potts, H. W. W., & Wardle, J. (2010). How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology, 40, 998–1009.CrossRef

Lam, W. Y., & Fresco, P. (2015). Medication adherence measures: an overview (pp. 12). BioMed Research International. https://doi.org/10.1155/2015/217047.

Lewis, M. A., Uhrig, J. D., Bann, C. M., Harris, J. L., Furberg, R. D., Coomes, C., & Kuhns, L. M. (2013). Tailored text messaging intervention for HIV adherence: a proof-of-concept study. Health Psychology, 32, 248–253.CrossRef

Liu, A. Y., Hessol, N. A., Vittinghoff, E., Amico, K. R., Kroboth, E., Fuchs, J., et al. (2014). Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care and STDs, 28, 622–627.CrossRef

McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868–2879.CrossRef

Mera Giler, R., Magnuson, D., Trevor, H., Bush, S., Rawlings, K., & McCallister, S. (2017). Changes in truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: (2012-2016). Paper presented at the 9th International AIDS Society Conference on HIV Science, Paris, France.

Miles, M. B., & Huberman, M. (1994). Qualitative data analysis: an expanded sourcebook. Thousand Oaks: Sage Publications.

Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., et al. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373, 2237–2246.

Neuendorf, K. A. (2002). The content analysis guidebook. Thousand Oaks: Sage.

Pantalone, D. W., Rood, B. A., Morris, B. W., & Simoni, J. M. (2014). A systematic review of the frequency and correlates of partner abuse in HIV-infected women and men who partner with men. Journal of the Association of Nurses in AIDS Care, 25, S15–S35.CrossRef

Parsons, J. T., Rendina, H. J., Grov, C., Ventuneac, A., & Mustanski, B. (2015). Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes, 68, 449–455.CrossRef

Patel, R. R., Mena, L., Nunn, A., McBride, T., Harrison, L. C., Oldenburg, C. E., et al. (2017). Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. PLoS One, 12, e0178737.CrossRef

Patrick, R., Forrest, D., Cardenas, G., Opoku, J., Magnus, M., Phillips, G. I., et al. (2017). Awareness, willingness, and use of pre-exposure prophylaxis among men who have sex with men in Washington, DC and Miami-Dade County, FL: National HIV behavioral surveillance, 2011 and 2014. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75, S375–S382.CrossRef

Patton, M. Q. (1990). Qualitative evaluation research (2nd ed.). Newbury Park: Sage Publications, Inc..

Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E., & Bangsberg, D. R. (2007). Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clinical Infectious Diseases, 45, 908–915.CrossRef

Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., et al. (2011). Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS, 25, 825–834.CrossRef

Remien, R. H., Mellins, C. A., Robbins, R. N., Kelsey, R., Rowe, J., Warne, P., et al. (2013). Masivukeni: Development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS and Behavior, 17, 1979–1991.CrossRef

Robbins, R. N., Spector, A. Y., Mellins, C. A., & Remien, R. H. (2014). Optimizing ART adherence: Update for HIV treatment and prevention. Current HIV/AIDS Reports, 11, 423–433.CrossRef

Rodrigues, R., Shet, A., Antony, J., Sidney, K., Arumugam, K., Krishnamurthy, S., et al. (2012). Supporting adherence to antiretroviral therapy with mobile phone reminders: Results from a cohort in South India. PLoS One, 7, e40723.CrossRef

Ronis, D. L., Yates, J. F., & Kirscht, J. P. (1989). Attitudes, decisions, and habits as determinants of repeated behavior. In A. R. Pratkan, S. J. Breckler, & A. G. Greenwald (Eds.), Attitude structure and function (pp. 213–239). Hillsdale: Lawrence Erlbaum Associates, Publishers.

Saldaña, J. (2013). The coding manual for qualitative research (2nd ed.). Thousand Oaks: Sage.

Scanlon, M. L., & Vreeman, R. C. (2013). Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl), 5, 1–17.

Schwartz, J., & Grimm, J. (2017). PrEP on Twitter: Information, barriers, and stigma. Health Communication, 32, 509–516.CrossRef

Shet, A., Costa, A. D., Kumarasamy, N., Rodrigues, R., Rewari, B. B., Ashorn, P., et al. (2014). Effect of mobile telephone reminders on treatment outcome in HIV: Evidence from a randomised controlled trial in India. BMJ [British Medical Journal], 349, g5978.

Simoni, J. M., Pearson, C. R., Pantalone, D. W., Crepaz, N., & Marks, G. (2006). Efficacy of highly active antiretroviral therapy interventions in improving adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes, 43, 523–535.CrossRef

Simoni, J. M., Pantalone, D. W., Plummer, M. D., & Huang, B. (2007). A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychology, 26, 488.CrossRef

Simoni, J. M., Nelson, K. M., Franks, J. C., Yard, S. S., & Lehavot, K. (2011). Are peer interventions for HIV efficacious? A systematic review. AIDS and Behavior, 15, 1589–1595.CrossRef

Snowden, J. M., Chen, Y. H., McFarland, W., & Raymond, H. F. (2017). Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: Implications for disparities. Sexually Transmitted Infections, 93, 52–55.CrossRef

Stawarz, K., Cox, A. L., & Blandford, A. (2015). Beyond self-tracking and reminders: designing smartphone apps that support habit formation. Paper presented at the Proceedings of the 33rd annual ACM conference on human factors in computing systems.

Sudore, R. L., & Schillinger, D. (2009). Interventions to improve care for patients with limited health literacy. Journal of clinical outcomes management: JCOM, 16, 20.PubMed

Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., et al. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25, 961–967. https://doi.org/10.1080/09540121.2012.748871.CrossRefPubMed

Taylor, S. W., Psaros, C., Pantalone, D. W., Tinsley, J., Elsesser, S. A., Mayer, K. H., & Safren, S. A. (2017). “Life-Steps” for PrEP adherence: Demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cognitive and Behavioral Practice, 24, 38–49.CrossRef

Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., et al. (2013). High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: Qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS and Behavior, 17, 2162–2172.CrossRef

Watters, J. K., & Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36, 416–430.CrossRef

Titel: Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study
verfasst von: Christian Grov
Anthony W. P. Flynn
Alexa B. D’Angelo
Javier Lopez-Rios
David W. Pantalone
Ian W. Holloway
Jeffrey T. Parsons
Publikationsdatum: 12.01.2019
Verlag: Springer US
Schlagwörter: Dental Prophylaxis
Human Immunodeficiency Virus
Erschienen in: Prevention Science / Ausgabe 1/2019
Print ISSN: 1389-4986
Elektronische ISSN: 1573-6695
DOI: https://doi.org/10.1007/s11121-019-0985-y

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Toward Tailored Interventions: Sympathetic and Parasympathetic Functioning Predicts Responses to an Intervention for Conduct Problems Delivered in Two Formats

A Randomized Controlled Trial to Reduce HIV-Related Risk in African American Men Who Have Sex with Men and Women: the Bruthas Project

Using Technology and Assessment to Personalize Instruction: Preventing Reading Problems

Precision Strategies as a Timely and Unifying Framework for Ongoing Prevention Science Advances

eHealth Familias Unidas: Efficacy Trial of an Evidence-Based Intervention Adapted for Use on the Internet with Hispanic Families

HIV Risk Among Displaced Adolescent Girls in Ethiopia: the Role of Gender Attitudes and Self-Esteem